These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3010486)

  • 21. Dual pathway clearance of 99mTc-DTPA from the bronchial mucosa.
    Bennett WD; Ilowite JS
    Am Rev Respir Dis; 1989 May; 139(5):1132-8. PubMed ID: 2653148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic and pulmonary clearance of exogenous vasoactive intestinal peptide in the rat.
    Humphrey CS; Murray P; Ebeid AM; Fischer JE
    Gastroenterology; 1979 Jul; 77(1):55-60. PubMed ID: 447028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of smoking on bronchial clearance of technetium-99m-DTPA and indium-113m-DTPA.
    Chinet T; Collignon MA; Lemarchand P; Barritault L; Huchon G
    J Nucl Med; 1995 Sep; 36(9):1569-72. PubMed ID: 7658211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in pulmonary clearance of technetium labelled DTPA during haemodialysis.
    Belcher NG; Rees PJ
    Thorax; 1986 May; 41(5):381-5. PubMed ID: 3529481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Positive end-expiratory pressure increases pulmonary clearance of inhaled 99mTc-DTPA in nonsmokers but not in healthy smokers.
    Nolop KB; Braude S; Royston D; Maxwell DL; Hughes JM
    Bull Eur Physiopathol Respir; 1987; 23(1):57-60. PubMed ID: 3297216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposomal vasoactive intestinal peptide for lung application: protection from proteolytic degradation.
    Stark B; Andreae F; Mosgoeller W; Edetsberger M; Gaubitzer E; Koehler G; Prassl R
    Eur J Pharm Biopharm; 2008 Sep; 70(1):153-64. PubMed ID: 18555674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased pulmonary and intestinal permeability in Crohn's disease.
    Adenis A; Colombel JF; Lecouffe P; Wallaert B; Hecquet B; Marchandise X; Cortot A
    Gut; 1992 May; 33(5):678-82. PubMed ID: 1612487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-frequency oscillatory ventilation increases canine pulmonary epithelial permeability.
    Man GC; Ahmed IH; Logus JW; Man SF
    J Appl Physiol (1985); 1987 Nov; 63(5):1871-6. PubMed ID: 2826384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of a high sodium diet on the metabolism and secretion of vasoactive intestinal peptide in the rabbit.
    Davis RE; Shelley S; MacDonald GJ; Duggan KA
    J Physiol; 1992; 451():17-23. PubMed ID: 1403810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Substance P, vasoactive intestinal polypeptide, and gastrin catabolism in canine liver and kidney.
    Kabemura T; Misawa T; Chijiiwa Y; Nasu T; Nawata H
    Dig Dis Sci; 1992 Nov; 37(11):1661-5. PubMed ID: 1385057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of infused vasoactive intestinal peptide on airway function in normal subjects.
    Palmer JB; Cuss FM; Warren JB; Blank M; Bloom SR; Barnes PJ
    Thorax; 1986 Sep; 41(9):663-6. PubMed ID: 3787552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.
    Petkov V; Mosgoeller W; Ziesche R; Raderer M; Stiebellehner L; Vonbank K; Funk GC; Hamilton G; Novotny C; Burian B; Block LH
    J Clin Invest; 2003 May; 111(9):1339-46. PubMed ID: 12727925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary clearance of 99mTc-DTPA: influence of background activity.
    Barrowcliffe MP; Otto C; Jones JG
    J Appl Physiol (1985); 1988 Mar; 64(3):1045-9. PubMed ID: 3284865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The temporal and spatial distribution of vasoactive intestinal peptide and its receptor in the development of airway hyperresponsiveness].
    Ren YH; Qin XQ; Guan CX; Luo ZQ; Zhang CQ; Sun XH
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):224-8. PubMed ID: 15144609
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of vasoactive intestinal peptide on isolated perfused rat kidney.
    Rosa RM; Silva P; Stoff JS; Epstein FH
    Am J Physiol; 1985 Nov; 249(5 Pt 1):E494-7. PubMed ID: 4061639
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain delivery of vasoactive intestinal peptide enhanced with the nanoparticles conjugated with wheat germ agglutinin following intranasal administration.
    Gao X; Wu B; Zhang Q; Chen J; Zhu J; Zhang W; Rong Z; Chen H; Jiang X
    J Control Release; 2007 Aug; 121(3):156-67. PubMed ID: 17628165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Failure of aerosolised 99mTc DTPA clearance to predict outcome in patients with adult respiratory distress syndrome.
    Royston D; Braude S; Nolop KB
    Thorax; 1987 Jul; 42(7):494-9. PubMed ID: 3326212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid improvement in abnormal pulmonary epithelial permeability after stopping cigarettes.
    Minty BD; Jordan C; Jones JG
    Br Med J (Clin Res Ed); 1981 Apr; 282(6271):1183-6. PubMed ID: 6788126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary epithelial clearance of 99mTc-DTPA after thrombin-induced pulmonary microembolism.
    Cooper JA; Feustel PJ; Line BR; Malik AB
    Am Rev Respir Dis; 1986 Oct; 134(4):734-8. PubMed ID: 3532885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of vasoactive intestinal peptide and calcitonin gene-related peptide on peptidoleukotriene release from platelet activating factor stimulated rat lungs and ionophore stimulated guinea pig lungs.
    Di Marzo V; Tippins JR; Morris HR
    Biochem Int; 1986 Dec; 13(6):933-42. PubMed ID: 2432897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.